Global Presence Venus Aesthetic Intelligence operates in over 60 countries with 29 direct markets, indicating a strong international footprint and opportunities to expand sales collaborations in emerging markets and regions with growing demand for aesthetic procedures.

Innovative Portfolio With cutting-edge devices like Venus Bliss MAX and ARTAS iXi powered by artificial intelligence, the company appeals to clinics seeking advanced, non-invasive aesthetic solutions, offering upsell potential for providers investing in the latest technology.

Growing Revenue Generating between $50 million and $100 million annually, Venus demonstrates solid revenue streams that can support expanded sales efforts, especially by targeting clinics and hospitals looking to upgrade their aesthetic technology offerings.

Recent Funding A recent $2.7 million financing round highlights ongoing investor confidence and financial stability, providing opportunities for strategic partnerships, joint ventures, or increased investment to boost sales and global reach.

Market Leadership As a leading player in the medical aesthetic industry with high treatment volumes worldwide, Venus presents a compelling case for sales teams to engage with top-tier clinics and providers seeking reputable, innovative devices to attract more clients.